Interventional cytopathology and cancer in Peru: how to act during COVID-19?
This article reviews the existing literature on interventional cytopathology, the risk of infection from SARS-CoV-2 and biosafety and provides recommendations for carrying out said procedures for the benefit of the patient and the safety of healthcare staff.
PMID: 33574897 [PubMed]
Source: Ecancermedicalscience - Category: Cancer & Oncology Tags: Ecancermedicalscience Source Type: research
More News: Cancer | Cancer & Oncology | Coronavirus | COVID-19 | Pandemics | Peru Health | Respiratory Medicine | SARS